• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM; DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1011707-38
Device Problems Material Separation (1562); Failure to Advance (2524); Difficult to Advance (2920); Material Split, Cut or Torn (4008)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/01/2023
Event Type  malfunction  
Event Description
It was reported that the procedure was to treat a lesion in anterior tibial artery with heavy calcification.The 2.5x38mm xience prime stent delivery system (sds) was advanced, but failed to cross the target lesion due to resistance with the anatomy.There was no adverse patient effect and no clinically significant delay reported in the procedure.The procedure was completed with balloon angioplasty.Return device analysis found multiple device separations.There was a separation noted in the support mandrel and there were 2 separations in the hypotube located 28mm and 38mm distally from distal end of hypotube jacket.The outer member was noted to be torn at the support mandrel separation.Follow up with the account reported that this was suspected to have occurred when the sds was being advanced or removed.No additional information was provided.
 
Manufacturer Narrative
The device was returned for analysis.A torn shaft and shaft separation were observed.The reported difficulty to advance and failure to advance could not be replicated in a testing environment as they were related to operational context of the procedure.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely the device interacted with the heavily calcified lesion causing the reported difficulty to advance and ultimately the reported failure to advance.Continued handling of the device in combination with interaction with the difficult anatomy during the attempted advancement to the lesion and/or removal from the difficult anatomy likely resulted in the reported torn and separated shaft.There is no indication of a product quality issue with respect to manufacture, design or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE PRIME LL EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18600927
MDR Text Key334142990
Report Number2024168-2024-01172
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeAS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 01/29/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/29/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1011707-38
Device Lot Number3051241
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/21/2023
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/04/2024
Was Device Evaluated by Manufacturer? No
Date Device Manufactured05/05/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-